BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 25759083)

  • 1. Two-year survival of patients screened for transcatheter aortic valve replacement with potentially malignant incidental findings in initial body computed tomography.
    Stachon P; Kaier K; Milde S; Pache G; Sorg S; Siepe M; von zur Mühlen C; Zirlik A; Beyersdorf F; Langer M; Zehender M; Bode C; Reinöhl J
    Eur Heart J Cardiovasc Imaging; 2015 Jul; 16(7):731-7. PubMed ID: 25759083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial.
    Kapadia SR; Leon MB; Makkar RR; Tuzcu EM; Svensson LG; Kodali S; Webb JG; Mack MJ; Douglas PS; Thourani VH; Babaliaros VC; Herrmann HC; Szeto WY; Pichard AD; Williams MR; Fontana GP; Miller DC; Anderson WN; Akin JJ; Davidson MJ; Smith CR;
    Lancet; 2015 Jun; 385(9986):2485-91. PubMed ID: 25788231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial.
    Mack MJ; Leon MB; Smith CR; Miller DC; Moses JW; Tuzcu EM; Webb JG; Douglas PS; Anderson WN; Blackstone EH; Kodali SK; Makkar RR; Fontana GP; Kapadia S; Bavaria J; Hahn RT; Thourani VH; Babaliaros V; Pichard A; Herrmann HC; Brown DL; Williams M; Akin J; Davidson MJ; Svensson LG;
    Lancet; 2015 Jun; 385(9986):2477-84. PubMed ID: 25788234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. End-stage renal disease and severe aortic stenosis: Does valve replacement improve one-year outcomes?
    Condado JF; Maini A; Leshnower B; Thourani V; Forcillo J; Devireddy C; Mavromatis K; Sarin EL; Stewart J; Guyton R; Simone A; Keegan P; Lerakis S; Block PC; Babaliaros V
    Catheter Cardiovasc Interv; 2017 May; 89(6):1109-1115. PubMed ID: 28211605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic outcomes of transcatheter aortic valve replacement and medical management in severe, inoperable aortic stenosis: a longitudinal echocardiographic study of cohort B of the PARTNER trial.
    Douglas PS; Hahn RT; Pibarot P; Weissman NJ; Stewart WJ; Xu K; Wang Z; Lerakis S; Siegel R; Thompson C; Gopal D; Keane MG; Svensson LG; Tuzcu EM; Smith CR; Leon MB
    J Am Soc Echocardiogr; 2015 Feb; 28(2):210-7.e1-9. PubMed ID: 25455544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of varying degrees of renal dysfunction on transcatheter and surgical aortic valve replacement.
    Nguyen TC; Babaliaros VC; Razavi SA; Kilgo PD; Guyton RA; Devireddy CM; Shults CC; Mavromatis K; Kanitkar M; Block P; Lerakis S; Thourani VH
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1399-406; discussion 13406-7. PubMed ID: 24075566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
    Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
    J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapy.
    Kapadia SR; Tuzcu EM; Makkar RR; Svensson LG; Agarwal S; Kodali S; Fontana GP; Webb JG; Mack M; Thourani VH; Babaliaros VC; Herrmann HC; Szeto W; Pichard AD; Williams MR; Anderson WN; Akin JJ; Miller DC; Smith CR; Leon MB
    Circulation; 2014 Oct; 130(17):1483-92. PubMed ID: 25205802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of transcatheter aortic valve implantation and surgical aortic valve replacement in 1,141 patients with severe symptomatic aortic stenosis and less than high risk.
    Schymik G; Heimeshoff M; Bramlage P; Herbinger T; Würth A; Pilz L; Schymik JS; Wondraschek R; Süselbeck T; Gerhardus J; Luik A; Gonska BD; Tzamalis P; Posival H; Schmitt C; Schröfel H
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):738-44. PubMed ID: 25641398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).
    Elmariah S; Palacios IF; McAndrew T; Hueter I; Inglessis I; Baker JN; Kodali S; Leon MB; Svensson L; Pibarot P; Douglas PS; Fearon WF; Kirtane AJ; Maniar HS; Passeri JJ;
    Circ Cardiovasc Interv; 2013 Dec; 6(6):604-14. PubMed ID: 24221391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of transcatheter aortic valve replacement availability and hospital aortic valve replacement volume and mortality in the United States.
    Brennan JM; Holmes DR; Sherwood MW; Edwards FH; Carroll JD; Grover FL; Tuzcu EM; Thourani V; Brindis RG; Shahian DM; Svensson LG; O'Brien SM; Shewan CM; Hewitt K; Gammie JS; Rumsfeld JS; Peterson ED; Mack MJ
    Ann Thorac Surg; 2014 Dec; 98(6):2016-22; discussion 2022. PubMed ID: 25443009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis.
    Herrmann HC; Pibarot P; Hueter I; Gertz ZM; Stewart WJ; Kapadia S; Tuzcu EM; Babaliaros V; Thourani V; Szeto WY; Bavaria JE; Kodali S; Hahn RT; Williams M; Miller DC; Douglas PS; Leon MB
    Circulation; 2013 Jun; 127(23):2316-26. PubMed ID: 23661722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter aortic valve replacement has improved short-term but similar midterm outcomes in isolated aortic valve replacement after prior coronary artery bypass grafting.
    Nguyen TC; Babaliaros VC; Razavi SA; Kilgo PD; Devireddy CM; Leshnower BG; Mavromatis K; Guyton RA; Kanitkar M; Lerakis S; Merlino J; Chen EP; Thourani VH
    Ann Thorac Surg; 2014 Oct; 98(4):1316-24. PubMed ID: 25149053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve).
    Williams M; Kodali SK; Hahn RT; Humphries KH; Nkomo VT; Cohen DJ; Douglas PS; Mack M; McAndrew TC; Svensson L; Thourani VH; Tuzcu EM; Weissman NJ; Kirtane AJ; Leon MB
    J Am Coll Cardiol; 2014 Apr; 63(15):1522-8. PubMed ID: 24561149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of transcatheter aortic valve implantation on surgical aortic valve.
    Vaquerizo B; Bleiziffer S; Wottke M; Spaziano M; Eschenbach L; Lange R; Piazza N
    Int J Cardiol; 2017 Sep; 243():145-149. PubMed ID: 28536003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous implantation of the CoreValve® self-expanding valve prosthesis in patients with severe aortic stenosis and porcelain aorta: medium-term follow-up.
    Pascual I; Avanzas P; Muñoz-García AJ; López-Otero D; Jimenez-Navarro MF; Cid-Alvarez B; del Valle R; Alonso-Briales JH; Ocaranza-Sanchez R; Alfonso F; Hernández JM; Trillo-Nouche R; Morís C
    Rev Esp Cardiol (Engl Ed); 2013 Oct; 66(10):775-81. PubMed ID: 24773857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Preoperative Chronic Kidney Disease in 2,531 High-Risk and Inoperable Patients Undergoing Transcatheter Aortic Valve Replacement in the PARTNER Trial.
    Thourani VH; Forcillo J; Beohar N; Doshi D; Parvataneni R; Ayele GM; Kirtane AJ; Babaliaros V; Kodali S; Devireddy C; Szeto W; Herrmann HC; Makkar R; Ailawadi G; Lim S; Maniar HS; Zajarias A; Suri R; Tuzcu EM; Kapadia S; Svensson L; Condado J; Jensen HA; Mack MJ; Leon MB
    Ann Thorac Surg; 2016 Oct; 102(4):1172-80. PubMed ID: 27592092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Risk Profile and Outcomes of Patients Undergoing Surgical Aortic Valve Replacement From the Pre- to Post-Transcatheter Aortic Valve Replacement Eras.
    Englum BR; Ganapathi AM; Schechter MA; Harrison JK; Glower DD; Hughes GC
    Ann Thorac Surg; 2016 Jan; 101(1):110-7. PubMed ID: 26384440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geometric changes in ventriculoaortic complex after transcatheter aortic valve replacement and its association with post-procedural prosthesis-patient mismatch: an intraprocedural 3D-TEE study.
    Utsunomiya H; Mihara H; Itabashi Y; Kobayashi S; Siegel RJ; Chakravarty T; Jilaihawi H; Makkar RR; Shiota T
    Eur Heart J Cardiovasc Imaging; 2017 Jan; 18(1):1-10. PubMed ID: 27025512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional surgery, sutureless valves, and transapical aortic valve replacement: what is the best option for patients with aortic valve stenosis? A multicenter, propensity-matched analysis.
    D'Onofrio A; Rizzoli G; Messina A; Alfieri O; Lorusso R; Salizzoni S; Glauber M; Di Bartolomeo R; Besola L; Rinaldi M; Troise G; Gerosa G
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1065-70; discussion 1070-1. PubMed ID: 24021955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.